Insulin aspart, recombinant Subcutaneous and Phenobarbital Sodium
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Phenobarbital Sodium and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: phenobarbital
Brand name: Solfoton, Luminal
Synonyms: Phenobarbital, PHENobarbital
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Phenobarbital Sodium Injection
- Insulin aspart, recombinant Subcutaneous-Phenobarbital Tablets
- Insulin aspart, recombinant Subcutaneous-Phenobarbital with Belladonna Alkaloids Elixir
- Insulin aspart, recombinant Subcutaneous-Phenohytro
- Insulin aspart, recombinant Subcutaneous-Phenohytro Elixir
- Insulin aspart, recombinant Subcutaneous-Phenoxybenzamine
- Phenobarbital Sodium-Insulin degludec
- Phenobarbital Sodium-Insulin Degludec (U-100) Prefilled Pens
- Phenobarbital Sodium-Insulin Degludec (U-100) Vials
- Phenobarbital Sodium-Insulin Degludec (U-200) Prefilled Pens
- Phenobarbital Sodium-Insulin degludec and liraglutide
- Phenobarbital Sodium-Insulin degludec and liraglutide Subcutaneous